Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

The Children's Place, Inc (PLCE.O)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2022-03-2550.1860.00Neutral
2022-05-3147.4856.00Neutral
2022-07-1540.7546.00Neutral
2022-11-1436.5443.00Neutral
2022-11-1738.9041.00Neutral
2023-01-0436.6038.00Neutral
2023-02-0745.5345.00Neutral
2023-03-2937.7840.00Neutral
2023-05-2517.3420.00Neutral
2023-09-0625.3829.00Neutral
2023-11-1719.1124.00Neutral
2024-06-109.8312.00Neutral
2024-09-1917.1618.00Neutral
2024-11-1714.0417.00Neutral
2024-12-1014.1415.00Neutral
2025-01-1010.3811.00Neutral
2025-03-037.769.00Neutral
2025-04-076.328.00Neutral
2025-04-145.757.00Neutral
2025-06-094.656.00Neutral

Disclosures

  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • Because this security exhibits higher-than-average volatility, the FSR has been set at 15% above the MRA for a Buy rating, and at -15% below the MRA for a Sell rating (compared with 6/-6% under the normal rating system).
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.